Covid-19

NEW DELHI: Bharat Biotech’s Covaxin has proven to be ‘safe, well-tolerated, and highly immunogenic’ in children in Phase II/III studies, the results of which are published in the prestigious Lancet journal. The study said that the data from over 50 million doses given to children in India reveals that side effects are minimal. The trials […]

NEW DELHI: In a worrying escalation of COVID cases across the country, India has recorded 12,213 new cases in the last 24 hours. In an alarming sign, this is the first time since February 26 the country had seen a single-day surge of more than 10,000 cases. On Wednesday, the Union health ministry reported 8,822 […]

NEW DELHI: With reports of a surge in COVID cases, Union health minister Dr Mansukh Mandaviya on Monday said that the COVID is not over yet. The ministry has registered 8,084 new cases in the last 24 hours. Speaking at a review meeting with the state health ministers on the present status and progress under […]

NEW DELHI: After a lull for almost three months, India recorded more than 5,000 COVID cases in the last 24 hours according to the Union Health ministry’s daily updates. On Tuesday 5,233 new cases were recorded in a single day spike in the last 24 hours. However, the trend shows an escalation in cases in […]

NEW DELHI: Vaccine Manufacturer Bharat Biotech’s Nasal Covid Vaccine, BBV154 has received approval to conduct Phase-3 clinical trials. BBV154 is an intranasal booster dose for people who have received both doses of Covaxin. The Drug Controller General Of India today gave approval for the Phase-3 trials. The Trials will be conducted at nine locations in the […]